A nurse in a pediatric clinic is providing teaching to the guardian of an infant who has a new prescription for digoxin.
Which of the following manifestations should the nurse include as an indication of digoxin toxicity?

Choice A rationale:

Bradycardia, or a slow heart rate, is a manifestation of digoxin toxicity. Digoxin, a medication commonly prescribed for heart conditions, can cause toxic effects when its levels become too high in the body. Bradycardia is a result of the drug's action on the heart's electrical conduction system and indicates toxicity.

Choice B rationale:

Diaphoresis, or excessive sweating, is not a specific manifestation of digoxin toxicity. While sweating can occur due to various reasons, it is not a characteristic sign of digoxin toxicity.

Choice C rationale:

Jaundice, or yellowing of the skin and eyes, is not a typical manifestation of digoxin toxicity. Jaundice is more commonly associated with liver or bile duct disorders.

Choice D rationale:

Polyuria, or excessive urination, is not a specific sign of digoxin toxicity. Digoxin toxicity primarily affects the heart and its electrical conduction system, leading to symptoms like bradycardia.

Choice A rationale:

Limb withdrawal is a pain response and indicates that the infant is experiencing pain. The goal of opioid pain medication is to alleviate pain, so limb withdrawal suggests inadequate pain control.

Choice B rationale:

A relaxed facial expression indicates that the infant is comfortable and not experiencing pain. It is a positive sign that the medication is having a therapeutic effect by providing pain relief.

Choice C rationale:

Increased blood pressure is not a typical response to opioid pain medication. Opioids often cause a decrease in blood pressure and can lead to hypotension.

Choice D rationale:

Bradycardia (slow heart rate) is not a common response to opioid pain medication. Opioids can cause respiratory depression and bradypnea (slow breathing), but they do not typically cause bradycardia.